The main signs of Alzheimer's disease (AD) are cognitive impairment and senile plaques composed of amyloid beta (A) observed in patients' brains. Therefore, therapy for AD focuses on the removal of A. We developed an ''edible vaccine'' that employs intestinal immunity with little to no side effects. Rice was utilized as an edible vaccine. It expressed GFP-A42. A rice was administered orally to wild-type (WT) mice causing production of anti-A antibodies. Since A rice was mixed with the cholera toxin B subunit (CTB), antibody against the rice seed protein was also produced. Then, mice were caused to develop immune tolerance against the rice seed protein by oral administration of A rice mixed with CTB. The results indicated that only anti-A antibodies were produced.
The main signs of Alzheimer's disease (AD) are cognitive impairment, amyloid beta (A)-containing senile plaques, and neurofibrillary tangles composed of tau observed in a patient's brain. 1) A is generated by proteolytic processing of the amyloid precursor protein (APP) by -and -secretases. The main species of A are A40 and A42. The longer A42 has a greater propensity to aggregate than the shorter A40. 2) In AD model mice, cognitive impairment was improved by inhibiting senile plaque formation by means of antibody production stimulated by vaccination. [3] [4] [5] Vaccination is an antibody therapy that works by timely production of antibodies against the proper antigen. However, in a clinical trial in which A42 peptide was administered to humans, meningoencephalitis was seen as a side effect and the clinical trial was discontinued. 6) Therefore, a therapy focusing on a mild antigen-antibody reaction is needed. We developed an edible vaccine that induced mild antigen-antibody reaction by oral administration of genetically modified plant-integrated A.
Edible vaccines expressing various antigens have been developed. One benefit of edible vaccines is that they can be maintained at room temperature, whereas peptide vaccines must be preserved at cold temperatures.
Furthermore, edible vaccines can eliminate the injection pain associated with traditional vaccines. 7) They act by stimulating the lymphatic immune system located in the intestines and suppressing the inflammatory Th1 response and enhancing the non-inflammatory Th2 response.
Previously, we expressed GFP-A42 on green pepper leaves. A antibodies were produced when the leaves were administered orally to AD model mice, Tg2576, successfully reducing the A accumulating in their brains. 8, 9) However, new edible vaccines must be developed because green pepper leaves are not easy to digest, and mass production of the antigen is limited.
Rice (cultivar Hayayuki) was chosen as the edible vaccine and, A was expressed as a GFP-fusion protein. GFP-A42 was introduced into the rice by the Agrobacterium method (Yoshida, submitted). We performed SDS-PAGE and Western blotting on transgenic rice extracts in urea buffer to detect A expression in the rice. Rice seeds were ground to a fine powder with a IFM-650D Millser (Iwatani International, Tokyo), and total proteins were extracted in urea-SDS buffer (50 mM Tris-HCl, pH 6.8, 8 M urea, 2% SDS, 5% 2-mercaptoethanol, and 20% glycerol) and centrifuged. We used mouse monoclonal antibody 6E10 as the primary antibody to detect A. 9) Then we quantified the expression of A using synthesized mouse IgG as the protein standard. The A concentration was calculated as 120 mg for 1 g of transgenic rice.
To study antibody production after vaccination and the precise immunological response, subcutaneous and oral immunization of wild-type (WT) B6 mice was performed starting at 6 weeks of age, and was continued for 6 weeks. All the animal experiments followed the guidelines for the regulation of animal experiments of The University of Tokyo. For subcutaneous immunization, each mouse was anesthetized with diethyl ether and injected with 100-200 mL of an emulsion of rice powder dissolved in PBS mixed with Freund's adjuvant (Wako Pure Chemical Industries, Osaka) at several points using a 21-gauge needle. For oral immunization, the mixture of A rice powder and CTB (Sigma-Aldrich, Tokyo) in 5% sucrose was delivered orally by syringe. We examined four groups of WT B6 mice. Five WT mice y To whom correspondence should be addressed. Tel/Fax: +81-3-5454-6739; E-mail: cishiura@mail.ecc.u-tokyo.ac.jp vaccinated orally with non-transgenic rice served as negative controls. The rest of the WT mice were immunized with GFP-A42 either subcutaneously (n ¼ 6) or orally (0.5 g/d (n ¼ 5) or 1.0 g/d (n ¼ 4). The mice in the orally administered group received an edible antigen once every week from 6 to 12 weeks of age, and the subcutaneous-injected mice received doses of vaccine biweekly. Two weeks after an A booster given at 12 weeks, whole blood was collected from the heart. GFP-A42 expressed in COS-7 cells was detected in serum from the mice immunized orally (1.0 g/d) and subcutaneously (Fig. 1A) . We quantified by ELISA and calculated the amounts of serum anti-A antibody (Fig. 1B) . 9) Compared to the WT rice control, the amount of serum anti-A antibody was significantly elevated in the groups receiving GFP-A.
Antibodies against rice seed protein can also be produced by intestinal immunity. That means that food allergy can occur in oral vaccination. We found that an antibody against rice seed protein, possibly prolamin or glutelin, was produced by induction with CTB ( Fig. 2A,  B) . To detect the antibody against rice seed protein in the serum, the serum was diluted 50 times from mice orally administrated A, and was diluted 100 times from mice subcutaneously injected. Rice seed protein-specific IgG responses were measured by ELISA with 20 mg/mL the rice storage protein extracted with 0.01% Triton X-100. 10) Verhasselt et al. reported that an antigen can be transferred from lactating mice to their progeny through breast milk. 11) We assumed that the B6 mice acquired immune tolerance through breast milk from lactating mice to which WT rice was administrated orally. In addition, we thought it more efficient to induce immune tolerance through breast-feeding rather than direct administration of WT rice to young mice. Per one lactating mother, six progeny (three male, three female) were prepared. We used two mother mice from the oral administration group and one from the subcutaneously injected group. The WT mice received an edible vaccine orally every week from 6 to 15 weeks of age, and other WT mice received doses of vaccine subcutaneously every 2 weeks. Two weeks after an A booster was given at 15 weeks, whole blood was collected from the heart. The experimental details are schematically shown in Fig. 2C . We found that the amount of antibody against rice proteins tends to be suppressed by oral administration of WT rice to lactating mothers (Fig. 2D , E). The T cell response could be tolerated because the production of the antibody against the rice seed protein is suppressed, but rice seed protein antibody production was not suppressed in mice without pretreatment. Though we tried to quantify the amount of rice protein-induced release of IL-4, -5, and -10 from spleen cells, we were not able to detect these by sandwich ELISA (data not shown).
After inducing immune tolerance by oral administration of WT rice to lactating mice, we investigated the production of anti-A antibodies. We found that they were significantly elevated in the group receiving A rice orally as compared to the group given WT rice (Fig. 3A) . Next we investigated which sites of A42 peptide were recognized. Using A1-16 (Peptide Institute, Osaka, Japan), A11-28 (Immuno-Biological Laboratories, Takasaki, Japan) and A25-35 peptide (Peptide Institute), epitope mapping of anti-A antibody was done by ELISA (Fig. 3B) . The results suggested that the antibodies produced by oral administration or subcutaneous injection recognized a wide variety of A epitopes, because no differences were observed among A1-16, A11-28, A25-35, and A1-42. A, GFP-A42 was expressed in COS-7 cells and its lysate was separated by SDS-PAGE. Serum was applied to detect anti-A antibody. GFP-A42 was detected in serum from mice fed A rice (1.0 g/d) and injected with the lysate of A rice. For controls, 6E10 and anti-GFP antibody were used. These antibodies also detected GFP-A. B, The amount of anti-A antibody in the serum was calculated ELISA. Serum samples were diluted 100Â in this assay. Mean AE SE.
Ã p < 0:05.
To check the safety of the edible vaccine, we examined the isotype of anti-seed protein antibody in the serum and looked for inflammatory reactions in mice vaccinated orally and subcutaneously. IgG1 is known to be the non-inflammatory Th2 isotype IgG, and IgG2a is the inflammatory Th1 isotype IgG. If the ratio of IgG1/ IgG2a exceeds 1, the humoral immune responses of the non-inflammatory Th2 act dominantly. Therefore, to quantify rice seed protein specific immunoglobulin subclasses produced by intestinal immunity (orally administration) and systemic immunity (subcutaneous injection), ELISA with IgG1 and IgG2a was done. The ratio of IgG1 to IgG2a (IgG1/IgG2a) was calculated. In all the groups, the ratio of IgG1/IgG2a exceeded 1, suggesting that feeding of A rice induced the Th2 response (data not shown).
The number of patients with AD continues to increase and this is predicted to become a major problem, but no effective therapy exists. 12, 13) According to the amyloid hypothesis, AD is triggered by an accumulation of A, and peculiar pathogenic changes, such as neurologic deficit, are seen in AD brains. 1) Therefore, the focus for therapy of AD is to suppress the production of A or to inhibit the deposition of A in the brain. 14) To remove A from the brain, antibody therapy via injection of A into the body was performed at the beginning of 2000, but meningoencephalitis appeared as a side effect. 6) Therefore, the conclusion was drawn that the therapy needs a mild antigen-antibody reaction with a noninflammatory response toward Th2.
Hence we started a study of edible vaccines. 8) Because edible vaccines work through intestinal immunity, which induces the Th2 reaction and produces antibodies, it was thought to have few side effects. We expressed GFP-A42 in green pepper leaves with Tobamovirus, and these lysates mixed with CTB were orally administrated to AD model mice, Tg2576. We succeeded in producing anti-A antibodies and decreased A in the mouse brains. We also observed that the edible vaccine induced a noninflammatory response toward Th2. A, The difference in the production of the antibody against the rice seed protein before and after immunization was investigated SDS-PAGE. After immunization, anti-rice seed proteins were observed in both oral (left) and subcutaneous injection (right). B, The amount of the antibody against the whole rice seed protein was calculated ELISA. C, Experimental protocol. Lactating mothers were orally administrated wild rice (0.2 g) every other day from delivery until weaning. D, Rice extract in urea-SDS buffer was applied to SDS gels, and the various sera was used to detect anti-rice seed protein antibody. The rice storage protein (15-19 kDa) was not detected in the serum from progeny of oral administration of WT rice to lactating mice (left). High antibody production was observed in the mice without prior administration of rice (right). Serum samples were diluted to 50Â in this assay. E, Amount of antibody against rice whole protein. The value of the newly developed anti-rice protein antibody due to A-rice is shown. Production against the rice protein was suppressed in mice whose mothers were orally administrated rice at the lactating stage. Mean AE SE.
We investigated to determine whether the antibody against A would be produced by oral administration of A rice to B6 mice, as in the case of green pepper leaves. Compared to the group with oral administration of WT rice, the amount of anti-A antibody increased significantly in the group subjected to oral administration of A rice and in that receiving subcutaneous injections (Fig. 1A, B) , but the antibody titer against A did not increase greatly. We found that the anti-A antibody titer was inversely correlated with the level of soluble intracerebral A42 in Tg2576 mice in the green pepper experiment.
9) The frequency of immunization was different in this rice experiment, and the possibility exists that the effect of CTB attenuates it, because the amounts of proteins in rice are larger than in green pepper leaves. In the case of transgenic rice expressing Chlamydophila psittaci (Cp. Psittaci) antigen (MOMP)-fused LTB, mice were fed large amounts of rice in order to produce an antibody against MOMP. 15) Additionally, immunizing the AD model mice for a long time is important to decrease senile plaques, so one can remove A in Tg2576 mice even if an antibody is produced in modest amounts. 16) Because we administered CTB orally, antibody against rice seed protein was produced. However, as for humans, some believe that one can suppress antibody production due to immune tolerance against rice seed proteins by eating rice frequently. Since it has been reported to induce immune tolerance through lactation, 11) we tried to produce an antibody against A by suppressing antibody production against rice seed proteins by administering lactating mice WT rice. Even if humans use an edible vaccine with CTB, the antibody against the rice seed proteins may be suppressed. However, because IgE rather than IgG is the main immunoglobulin produced in food allergy, the production of IgE must also be also investigated in the future. Although the antibody against CTB was reportedly produced by the rice that expressed CTB, the antibody against the rice seed protein was not produced. 10) Therefore, rice expressing A with CTB might not produce antibody against rice seed protein, when immune tolerance is induced.
We performed epitope mapping and found that various antibodies were produced. The antibodies recognizing the N-terminus, such as A1-6, are efficient at inhibiting the formation of senile plaques, and the antibody used in the clinical trials has tandem repeats recognizing the N-terminus. [17] [18] [19] This food vaccine must improve a DNA construct to produce the antibody recognizing the N-terminus effectively and to fuse oral adjuvants such as CTB, instead of GFP for clinical use. Furthermore, we examined the T-cell response by calculating IgG1/IgG2a. In our system, intestinal immunity is thought to act dominantly on the Th2 immune response.
In this study, we were able to confirm the possibility of a vaccine treatment for AD. Rice is valuable as an edible vaccine because the effect of the vaccine reportedly is not lost even if the rice is preserved at room temperature for more than 1 year.
10) However, we must use AD model mice in future studies and examine the utility of the vaccine in AD therapy.
